Heiliczer, S.; Wilensky, A.; Gaver, T.; Georgiev, O.; Hamad, S.; Nemirovski, A.; Hadar, R.; Sharav, Y.; Aframian, D.J.; Tam, J.;
et al. Salivary Endocannabinoid Profiles in Chronic Orofacial Pain and Headache Disorders: An Observational Study Using a Novel Tool for Diagnosis and Management. Int. J. Mol. Sci. 2022, 23, 13017.
https://doi.org/10.3390/ijms232113017
AMA Style
Heiliczer S, Wilensky A, Gaver T, Georgiev O, Hamad S, Nemirovski A, Hadar R, Sharav Y, Aframian DJ, Tam J,
et al. Salivary Endocannabinoid Profiles in Chronic Orofacial Pain and Headache Disorders: An Observational Study Using a Novel Tool for Diagnosis and Management. International Journal of Molecular Sciences. 2022; 23(21):13017.
https://doi.org/10.3390/ijms232113017
Chicago/Turabian Style
Heiliczer, Shimrit, Asaf Wilensky, Tal Gaver, Olga Georgiev, Sharleen Hamad, Alina Nemirovski, Rivka Hadar, Yair Sharav, Doron J. Aframian, Joseph Tam,
and et al. 2022. "Salivary Endocannabinoid Profiles in Chronic Orofacial Pain and Headache Disorders: An Observational Study Using a Novel Tool for Diagnosis and Management" International Journal of Molecular Sciences 23, no. 21: 13017.
https://doi.org/10.3390/ijms232113017
APA Style
Heiliczer, S., Wilensky, A., Gaver, T., Georgiev, O., Hamad, S., Nemirovski, A., Hadar, R., Sharav, Y., Aframian, D. J., Tam, J., & Haviv, Y.
(2022). Salivary Endocannabinoid Profiles in Chronic Orofacial Pain and Headache Disorders: An Observational Study Using a Novel Tool for Diagnosis and Management. International Journal of Molecular Sciences, 23(21), 13017.
https://doi.org/10.3390/ijms232113017
